Glancy Prongay & Murray LLP Announces Investigation on Behalf of Opko Health, Inc. Investors

LOS ANGELES--()--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Opko Health, Inc. (“Opko” or the “Company”) (NASDAQ: OPK) investors concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On September 7, 2018, the U.S. Securities and Exchange Commission (“SEC”) filed a lawsuit against Opko and its CEO and Chairman Phillip Frost, alleging that Opko and Frost engaged in pump-and-dump schemes. On this news, Opko’s share price fell $1.01 per share, or more than 18%, before trading was halted on September 7, 2018, thereby injuring investors.

If you purchased Opko securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Release Summary

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Opko Health, Inc. Investors

$Cashtags

Contacts

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com